Acute skeletal muscle loss in SARS-CoV-2 infection contributes to poor clinical outcomes in COVID-19 patients,Journal of Cachexia, Sarcopenia and Muscle

当前位置： X-MOL 学术 › J. Cachexia Sarcopenia Muscle › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Acute skeletal muscle loss in SARS-CoV-2 infection contributes to poor clinical outcomes in COVID-19 patients
Journal of Cachexia, Sarcopenia and Muscle ( IF 8.9 ) Pub Date : 2022-07-19 , DOI: 10.1002/jcsm.13052
Amy Attaway _{1,

2} , Nicole Welch _{3,

4} , Dhweeja Dasarathy ₅ , Jocelyn Amaya-Hughley ₄ , Annette Bellar ₄ , Michelle Biehl _{1,

2} , Siddharth Dugar ₂ , Marielle P K J Engelen ₆ , Joe Zein _{1,

2,

4} , Srinivasan Dasarathy _{3,

4}

Affiliation

Chronic disease causes skeletal muscle loss that contributes to morbidity and mortality. There are limited data on the impact of dynamic muscle loss on clinical outcomes in COVID-19. We hypothesized that acute COVID-19-related muscle loss (acute sarcopenia) is associated with adverse outcomes.

中文翻译：